Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Chemotherapy in AIDS-Related Lymphoma
NCT00002524Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 1993
- Primary completion
- Oct 2005
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of bleomycin, cyclophosphamide, doxorubicin, vincristine, prednisone and 6 more in AIDS-related lymphoma (3 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Number of Patients with Clinical Response at 3 years. Started Jun 1993; status: completed.
02
Drugs
bleomycincyclophosphamidedoxorubicinvincristineprednisone
03
Conditions
AIDS-related lymphoma
Beyond the preview
Go deeper on NCT00002524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002524.